Anne Dørum

5.6k total citations
71 papers, 1.8k citations indexed

About

Anne Dørum is a scholar working on Reproductive Medicine, Genetics and Oncology. According to data from OpenAlex, Anne Dørum has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Reproductive Medicine, 32 papers in Genetics and 21 papers in Oncology. Recurrent topics in Anne Dørum's work include Ovarian cancer diagnosis and treatment (35 papers), BRCA gene mutations in cancer (30 papers) and Cancer Genomics and Diagnostics (11 papers). Anne Dørum is often cited by papers focused on Ovarian cancer diagnosis and treatment (35 papers), BRCA gene mutations in cancer (30 papers) and Cancer Genomics and Diagnostics (11 papers). Anne Dørum collaborates with scholars based in Norway, Sweden and United States. Anne Dørum's co-authors include Alv A. Dahl, Claes G. Tropé, Trond Melbye Michelsen, Astrid H. Liavaag, Pål Møller, D. Gareth Evans, Diane Provencher, Sophie D. Fosså, Susan L. Neuhausen and Susan Bishop and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anne Dørum

71 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Dørum Norway	24	882	865	553	332	280	71	1.8k
Amy Finch Canada	18	957 1.1×	1.1k 1.3×	333 0.6×	198 0.6×	256 0.9×	29	1.6k
Nina Ditsch Germany	24	202 0.2×	485 0.6×	555 1.0×	513 1.5×	187 0.7×	116	1.8k
James P. LaPolla United States	18	607 0.7×	368 0.4×	453 0.8×	486 1.5×	139 0.5×	33	1.7k
Leigha Senter United States	23	412 0.5×	971 1.1×	904 1.6×	474 1.4×	925 3.3×	74	2.2k
Lucy Side United Kingdom	23	227 0.3×	956 1.1×	466 0.8×	407 1.2×	218 0.8×	50	1.8k
Susan Randall Armel Canada	21	338 0.4×	963 1.1×	536 1.0×	331 1.0×	251 0.9×	51	1.5k
A Shenton United Kingdom	24	307 0.3×	1.2k 1.4×	664 1.2×	443 1.3×	606 2.2×	43	2.3k
Joan H. Marks United States	6	370 0.4×	1.3k 1.4×	432 0.8×	658 2.0×	255 0.9×	13	1.8k
Dirk Bauerschlag Germany	25	355 0.4×	239 0.3×	641 1.2×	1.1k 3.4×	184 0.7×	121	2.4k
Mariana Steiner Israel	18	369 0.4×	339 0.4×	1.3k 2.3×	614 1.8×	169 0.6×	31	1.9k

Countries citing papers authored by Anne Dørum

Since Specialization

Citations

This map shows the geographic impact of Anne Dørum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Dørum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Dørum more than expected).

Fields of papers citing papers by Anne Dørum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Dørum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Dørum. The network helps show where Anne Dørum may publish in the future.

Co-authorship network of co-authors of Anne Dørum

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Dørum. A scholar is included among the top collaborators of Anne Dørum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Dørum. Anne Dørum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bentzen, Anne Gry, Elisabeth Berge Nilsen, Ingvild Vistad, et al.. (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. International Journal of Gynecological Cancer. 33(12). 1898–1905. 4 indexed citations

Liavaag, Astrid H., et al.. (2017). Use of hormone replacement therapy after risk‐reducing salpingo‐oophorectomy. Acta Obstetricia Et Gynecologica Scandinavica. 96(5). 547–555. 17 indexed citations

Lindemann, Kristina, Emma Gibbs, Elisabeth Åvall‐Lundqvist, et al.. (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer. 116(4). 455–463. 36 indexed citations

Fabbro, Michel, Kathleen N. Moore, Anne Dørum, et al.. (2017). Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC). Annals of Oncology. 28. v332–v332. 7 indexed citations

Bjørnslett, Merete, Alv A. Dahl, Øystein Sørebø, & Anne Dørum. (2015). Psychological distress related to BRCA testing in ovarian cancer patients. Familial Cancer. 14(4). 495–504. 21 indexed citations

Bjørnslett, Merete, Stian Knappskog, Per Eystein Lønning, & Anne Dørum. (2012). Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers. BMC Cancer. 12(1). 454–454. 10 indexed citations

Michelsen, Trond Melbye, Anne Dørum, Milada Cvancarova, Astrid H. Liavaag, & Alv A. Dahl. (2012). Association between Hysterectomy with Ovarian Preservation and Cardiovascular Disease in a Norwegian Population-Based Sample. Gynecologic and Obstetric Investigation. 75(1). 61–67. 18 indexed citations

Kurtz, Jean‐Emmanuel, Marie‐Christine Kaminsky, Anne Floquet, et al.. (2011). Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Annals of Oncology. 22(11). 2417–2423. 37 indexed citations

Michelsen, Trond Melbye, Anne Dørum, & Alv A. Dahl. (2009). A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. Gynecologic Oncology. 113(1). 128–133. 36 indexed citations

10.

Michelsen, Trond Melbye, Are Hugo Pripp, Serena Tonstad, Claes G. Tropé, & Anne Dørum. (2008). Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: A controlled observational study. European Journal of Cancer. 45(1). 82–89. 53 indexed citations

11.

Liavaag, Astrid H., Anne Dørum, Trine Bjøro, et al.. (2007). A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach. Gynecologic Oncology. 108(2). 348–354. 65 indexed citations

12.

Monstad, Sissel E., Anne Dørum, Per Eystein Lønning, et al.. (2006). Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique. Cancer Immunology Immunotherapy. 55(10). 1280–1284. 20 indexed citations

13.

Dørum, Anne, et al.. (2005). Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: An autopsy study. American Journal of Obstetrics and Gynecology. 192(1). 48–54. 52 indexed citations

14.

Davidson, Ben, Zhijun Xi, Tove Irene Klokk, et al.. (2005). Kallikrein 4 Expression Is Up-Regulated in Epithelial Ovarian Carcinoma Cells in Effusions. American Journal of Clinical Pathology. 123(3). 360–368. 17 indexed citations

15.

Narod, Steven A., Harvey A. Risch, Roxana Moslehi, et al.. (1999). Oral Contraceptives and the Risk of Hereditary Ovarian Cancer. Obstetrical & Gynecological Survey. 54(1). 33–34. 34 indexed citations

16.

Dørum, Anne, Ketil Heimdal, Eivind Hovig, Mats Inganäs, & Pål Møller. (1999). Penetrances of BRCA1 1675delA and 1135insA with Respect to Breast Cancer and Ovarian Cancer. The American Journal of Human Genetics. 65(3). 671–679. 25 indexed citations

17.

Narod, Steven A., Harvey A. Risch, Roxana Moslehi, et al.. (1998). Oral Contraceptives and the Risk of Hereditary Ovarian Cancer. New England Journal of Medicine. 339(7). 424–428. 385 indexed citations

18.

Andersen, Tone Ikdahl, Hans Geir Eiken, Fergus J. Couch, et al.. (1998). Constant denaturant gel electrophoresis (CDGE) inBRCA1 mutation screening. Human Mutation. 11(2). 166–174. 16 indexed citations

19.

Dørum, Anne, Pål Møller, Erik-Jan Kamsteeg, et al.. (1997). A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. European Journal of Cancer. 33(14). 2390–2392. 21 indexed citations

20.

Dørum, Anne & Britt‐Ingjerd Nesheim. (1991). Monochorionic monoamniotic twins—the most precarious of twin pregnancies. Acta Obstetricia Et Gynecologica Scandinavica. 70(4-5). 381–383. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact